SCHEMBL175160

SCHEMBL175160

COc1c[c]ccc1-n1ccnc1C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ICMT O60725 2/20 0.37
CYP3A4 P08684 3/20 0.37
CYP2E1 P05181 1/20 0.37
CYP2A6 P11509 1/20 0.37
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP2D6 P10635 1/20 0.36
CYP19A1 P11511 1/20 0.36
ALDH1A1 P00352 3/20 0.36
RECQL P46063 1/20 0.35
SCN9A Q15858 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
TUBB4A P04350 1/20 0.34
TUBB P07437 1/20 0.34
TUBA3C P0DPH7 1/20 0.34
TUBA1B P68363 1/20 0.34
TUBA4A P68366 1/20 0.34
TUBB4B P68371 1/20 0.34
TUBB3 Q13509 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL246457 0.78 CYP3A4 (0.39) CYP3A4CYP2E1CYP2A6CYP1A2CYP2C9
SCHEMBL10904420 0.78 GAA (0.47) CYP3A4CYP2E1CYP2A6ALDH1A1SMN1; SMN2
SCHEMBL15218939 0.73 NR4A1 (0.54) ICMTCYP3A4CYP2E1CYP2A6CYP1A2
SCHEMBL2451209 0.70 PSEN1 (0.44) KCNH2
SCHEMBL2517633 0.70 PSEN1 (0.36) CYP3A4CYP2C9CYP2C19CYP2D6KCNH2
SCHEMBL196349 0.70 ALDH1A1 (0.56) CYP3A4CYP2E1CYP2A6CYP1A2CYP2C9
SCHEMBL61338 0.68 CYP3A4 (0.57) ICMTCYP3A4CYP2E1CYP2A6CYP1A2
SCHEMBL15218938 0.68 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2HTTKDM4EKMT2A
SCHEMBL8502061 0.67 CYP3A4 (0.47) ICMTCYP3A4CYP2E1CYP2A6CYP1A2
SCHEMBL10902395 0.67 ICMT (0.53) ICMTCYP3A4CYP2E1CYP2A6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611805-A1 FUSED TRIAZOLES FOR THE TREATMENT OR PROPHYLAXIS OF MILD COGNITIVE IMPAIRMENT Takeda Pharmaceutical Company Limited (JP) 2013-07-10 EP disclosed
WO-2012029991-A1 FUSED TRIAZOLES FOR THE TREATMENT OR PROPHYLAXIS OF MILD COGNITIVE IMPAIRMENT TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-08 WO disclosed